Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
14.52 USD | +0.07% | -2.28% | -14.71% |
May. 06 | Bausch + Lomb Shares Rise After Morgan Stanley Upgrade | MT |
May. 06 | Morgan Stanley Upgrades Bausch + Lomb to Overweight From Equalweight, Raises Price Target to $18 From $16 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.71% | 5.1B | |
-6.64% | 180B | |
+3.36% | 112B | |
-3.65% | 68.53B | |
+5.20% | 51.97B | |
+5.60% | 44.08B | |
+5.62% | 42.23B | |
+24.69% | 32.43B | |
+16.72% | 26.39B | |
-3.72% | 24.97B |
- Stock Market
- Equities
- BLCO Stock
- News Bausch + Lomb Corporation
- Bausch + Lomb Brief: Appointing Bob Bailey as Executive Vice President and Chief Legal Officer and Andrew Stewart as President, Ophthalmic Pharmaceuticals